The shortage of anti -cancer drugs in the United States allows the increase in imports

The US regulatory agency allows imported an anti -cancer drug from China to obtain additional supply.

According to BloomberApplication for distribution of key cancer chemotherapy).

The current drug is facing a national supply shortage in the United States, causing doctors to have to fulfill the distribution, and the patient's life is in risk.

Bloomberg reports that when a drug has a shortage in the United States, FDA usually allows imports, and import objects are companies that produce such drugs that are not approved by the United States.